Has Randa Jaafar received payments from drug or device companies?

Yes. Drug and device makers reported $87,424 in general payments to Randa Jaafar across 539 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Randa Jaafar did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Randa Jaafar come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Randa Jaafar

Pain Medicine · New York, NYNPI 1619126208

Payments from drug & device makers

$87,424in general payments, 2019–2025

Across 539 payments — averaging $162.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$53K
Boston Scientific$21K
Nevro Corp.$4K
Kowa Pharmaceuticals America, Inc.$2K
Merz North America, Inc.$1K
Amgen$883
plus $5K from 45 others

What the payments were for

Consulting fees$5,3006%
Speaking & faculty fees$51,64559%
Travel & lodging$10,07012%
Food & beverage$20,41023%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	210	$53,166
Boston Scientific	77	$21,181
Nevro Corp.	44	$3,773
Kowa Pharmaceuticals America, Inc.	11	$1,958
Merz North America, Inc.	8	$1,103
Amgen(2 entities)	37	$883
AbbVie(2 entities)	36	$747
Medtronic(2 entities)	9	$542
Stimwave Technologies Incorporated	3	$368
MML US, Inc.	5	$244
Highridge Medical LLC	2	$236
BD	1	$235
Merz Pharmaceuticals, LLC	7	$216
Pfizer	5	$174
Terumo Medical Corporation	1	$163
Neuronetics, Inc.	2	$154
Axsome Therapeutics, Inc.	2	$150
Phathom Pharmaceuticals, Inc.	1	$143
Nalu Medical, Inc.	1	$139
Vertiflex, Inc.	1	$132
EBI, LLC	1	$126
Teleflex LLC	1	$126
Teva Pharmaceuticals USA, Inc.	12	$126
Saluda Medical Americas, Inc.	1	$122
Collegium Pharmaceutical, Inc.	6	$117
Arbor Pharmaceuticals, Inc.	7	$114
Lundbeck LLC	4	$94
Scilex Pharmaceuticals Inc.	5	$76
Azurity Pharmaceuticals, Inc.	4	$73
Almatica Pharma LLC	3	$72
Orexo US, Inc.	4	$68
Biodelivery Sciences International, Inc.	3	$54
Abbott	1	$54
Shionogi Inc	3	$53
Curonix LLC	1	$47
Galderma Laboratories, L.p.	2	$44
Daiichi Sankyo Inc.	3	$43
Royal Biologics, Inc.	1	$36
Redhill Biopharma Inc.	2	$35
Lilly USA, LLC	1	$27
Biohaven Pharmaceutical Holding Company Ltd.	1	$25
Stryker	1	$25
Si-bone, Inc.	1	$24
Solta Medical, A Division Of Bausch Health US, LLC	1	$23
GRT US Holding, Inc.	1	$21
Hikma Pharmaceuticals USA	1	$19
Pacira Therapeutics, Inc.	1	$18
Assertio Therapeutics, Inc.	1	$17
Baudax Bio Inc.	1	$15
AstraZeneca	1	$13
Sentynl Therapeutics, Inc.	1	$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

LUCEMYRA$28,509
RELISTOR$22,018
SPECTRA WAVEWRITER$16,758
Senza Spinal Cord Stimulation System$2,082
Seglentis$1,700
WaveWriter Alpha Prime 16$1,528
GENERAL PAIN MANAGEMENT$807
Biomet SpinalPak Non-invasive Spine Fusion Stimulator System$362
Azur CX Detachable$325
COVEREDGE$268
Omnia$264
VECTRIS$240
Senza$235
Provena Midline$235
XEOMIN$163
HydroPearl$163
Navicross$163
SUPERION$151
BOTOX$150
KRYSTEXXA$150

How this compares

$87,424 in reported general payments places this provider in the 95th percentile of 503 pain medicine providers in New York.

See all pain medicine providers in New York →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Famotidine	11	$117

Paid to pharmacies, not to this prescriber.

Other pain medicine in New York

Amitabh GulatiNew York$627K
David SpinnerNew York$391K
Eric LeeNew York$156K
Christopher GhariboNew York$94K
Boris LeybelNew York$58K
Chirag ShahNew York$48K
Annie Layno-MosesNew York$29K
Raj MurthyNew York$24K
David CassagnolNew York$22K
Scott MaddaloNew York$22K

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →